Use of adalimumab in poststreptococcal reactive arthritis

Journal of Clinical Rheumatology

Volumn 13, Issue 3, 2007, Pages 176-

  Sánchez Cano, Daniel ^a   Callejas Rubio, José Luis ^a   Ortego Centeno, Norberto ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; HLA B27 ANTIGEN; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD EXAMINATION; CASE REPORT; FEMALE; FEVER; HUMAN; IMMUNOTHERAPY; OSTEOPENIA; PHARYNGITIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SORE THROAT; STREPTOCOCCUS INFECTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, REACTIVE; FEMALE; HUMANS; STREPTOCOCCAL INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250005438     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3180690c1f     Document Type: Article

References (2)

1. Flagg SD, Meador R, Hsia E, et al. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum. 2005;53:613-617.
2. Shulman ST, Ayoub EM. Poststreptococcal reactive arthritis. Curr Opin Rheumatol. 2002;14:562-565.